Assignee
IDOGEN AB
SE·1 granted patent·7 pending applications·0 citations·filing 2014–2019
Top patents by PatentIndex Score
8 records- 0149US2020078453A1Methods of treating a mammal suffering from or susceptible to an immune reaction to drug treatmentIDOGEN AB·Filed 2019·Application pending·0 cites
- 0244US9839674B2Methods of inducing indolamine 2,3—dioxygenase (IDO)IDOGEN AB·Filed 2014·Granted Dec 12, 2017·0 cites·11 claims
- 0335US2018028621A1Methods of inducing indolamine 2,3 - dioxygenase (ido)IDOGEN AB·Filed 2017·Application pending·0 cites
- 0430US2017014499A1Novel treatment methodIDOGEN AB·Filed 2016·Application pending·0 cites
- 0529US2019201431A1Ex vivo methods of inducing ido expression in antigen presenting cells using a compound selected from the group consisting of azacytidine, and decitabineIDOGEN AB·Filed 2017·Application pending·0 cites
- 0629US2019192543A1Novel useIDOGEN AB·Filed 2017·Application pending·0 cites
- 0729US2021299069A1Psammaplin a for modulating ido expressionIDOGEN AB·Filed 2017·Application pending·0 cites
- 0827US2016068809A1Use of zeburaline for the treatment of autoimmune diseases or immune rejection of transplantsIDOGEN AB·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when IDOGEN AB files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →